Sangamo BioSciences | DETTE

Debt Changement Date
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 64.61B 4.15B 2023-12
Bayer EUR 47.42B 907M 2023-09
BioCryst Pharmaceuticals USD 833.18M 13.88M 2023-09
Biogen USD 6.94B 348.2M 2023-12
BioMarin Pharmaceutical USD 1.09B 988K 2023-12
Bluebird Bio USD 0 0 2022-06
Clal Biotechnology ILS 7.49M 405K 2022-12
Compugen USD 0 0 2022-06
CSL USD 12.23B 108.4M 2023-06
Gilead Sciences USD 24.98B 264M 2023-09
GlaxoSmithKline GBP 20.84B 638M 2023-09
Grifols EUR 11.06B 1.03B 2023-09
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Merck USD 34.86B 2.05B 2023-09
Novartis USD 210M 28.09B 2023-09
Omeros USD 442.16M 199K 2023-09
Pfizer USD 63.6B 1.74B 2023-09
Regulus Therapeutics USD 2.13M 794K 2023-09
Roche Holding CHF 25.39B 35M 2023-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Sangamo BioSciences DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.